ClinicalTrials.gov
public full text
Public Domain
Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET
This study will formally address the hypothesis that FES-PET/CT measurement of ER expression predicts clinical benefit of first-line endocrine therapy in newly diagnosed ER+ metastatic breast cancer patients and establishes the repeatability of FES PET/CT.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Characterizing Breast Cancer With 18F-FES PET/CT#863733
- [18F]FES PET/.CT in Uterine Cancer#832044
- FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer#829011
- [18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib#889172
- [18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy#847290
Record · ID 909882
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive